The development and validation of a generic instrument, QoDoS, for assessing the quality of decision making
Introduction: The impact of decision making during the development and the regulatory review of medicines greatly influences the delivery of new medicinal products. Currently, there is no generic instrument that can be used to assess the quality of decision making. This study describes the developme...
Saved in:
Main Authors: | Ronan Donelan (Author), Stuart Walker (Author), Sam Salek (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Reliability and Relevance of a Quality of Decision Making Instrument, Quality of Decision-Making Orientation Scheme (QoDoS), for Use During the Lifecycle of Medicines
by: Magdalena Bujar, et al.
Published: (2019) -
A Process for Evaluating Quality Decision-Making Practices During the Development, Review and Reimbursement of Medicines
by: Magdalena Bujar, et al.
Published: (2022) -
A practical approach to communicating benefit-risk decisions of medicines to stakeholders
by: James eLeong, et al.
Published: (2015) -
Strategy for communicating benefit-risk decisions: A comparison of regulatory agencies' publicly available documents
by: James eLeong Wai Yeen, et al.
Published: (2014) -
Assessment of the effectiveness and efficiency of the West Africa medicines regulatory harmonization initiative by the member countries
by: Mercy Owusu-Asante, et al.
Published: (2022)